Optimising management of delirium [4] (multiple letters)

British Medical Journal

Volumn 322, Issue 7302, 2001, Pages 1602-1603

  Ryan, C J ^a   Tabet, N ^a   Howard, R ^a   Meagher, D ^a   Haines, J ^a   Barclay, P ^a   Wauchob, T ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DROPERIDOL; HALOPERIDOL; NEUROLEPTIC AGENT; PLACEBO;

CLINICAL FEATURE; CLINICAL RESEARCH; DELIRIUM; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG SENSITIVITY; HUMAN; LETTER; METHODOLOGY; NURSE; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

EID: 0035974508     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)